智通财经APP讯,友芝友生物-B(02496)发布公告,于2025年5月27日,根据2024年H股购股权计划条款向四名合资格参与者授出合共355万份购股权,可认购355万股H股,惟须待承授人接纳购股权后方可作实。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.